V-BETA-SPECIFIC ACTIVATION OF T-CELLS BY THE HIV GLYCOPROTEIN GP160

被引：0
|
作者：
AKOLKAR, PN
GULWANIAKOLKAR, BG
CHIRMULE, N
KALYANARAMAN, VS
PAHWA, S
MACPHAIL, S
SILVER, J
机构：
[1] N SHORE UNIV HOSP,CORNELL UNIV MED COLL,DEPT MED,MANHASSET,NY 11030
[2] N SHORE UNIV HOSP,CORNELL UNIV MED COLL,DEPT PEDIAT,MANHASSET,NY 11030
[3] N SHORE UNIV HOSP,CORNELL UNIV MED COLL,DEPT SURG,MANHASSET,NY 11030
[4] ADV BIOSCI LABS INC,DEPT CELL BIOL,KENSINGTON,MD 20895
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 1994年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [41] ENVELOPE-SPECIFIC ANTIBODIES IN THE SALIVA OF INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-1 GP160
    VASUDEVACHARI, MB
    UFFELMAN, KW
    KOVACS, J
    YEH, CK
    LANE, HC
    SALZMAN, NP
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (08): : 817 - 821
  • [42] DIFFERENTIAL PATTERNS OF BV-SPECIFIC ACTIVATION OF T-CELLS BY GP120 FROM DIFFERENT HIV STRAINS
    AKOLKAR, PN
    GULWANIAKOLKAR, B
    SILVER, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S107 - S107
  • [43] Inhibition of HIV-1 infection by an intramolecular antisense peptide to T20 in gp160
    Imai, M
    Okada, N
    Okada, H
    MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (03) : 205 - 212
  • [44] HIV-1 gp160 induces transforming growth factor-beta production in human PBMC
    Hu, R
    Oyaizu, N
    Than, S
    Kalyanaraman, VS
    Wang, XP
    Pahwa, S
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (03): : 283 - 289
  • [45] A VACCINIA-GP160-BASED VACCINE BUT NOT A GP160 PROTEIN VACCINE ELICITS ANTI-GP160 CYTOTOXIC T-LYMPHOCYTES IN SOME HIV-1 SERONEGATIVE VACCINEES
    PERALES, MA
    SCHWARTZ, DH
    FABRY, JA
    LIEBERMAN, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (01): : 27 - 35
  • [46] CYTOKINE AND P24 PROFILES IN GP160, GP120, AND TETANUS SPECIFIC T-LYMPHOCYTE LINES FROM HIV-SEROPOSITIVE PATIENTS
    SITZ, KV
    RATTO, S
    MANCA, F
    REDFIELD, RR
    BIRX, DL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 361 - 361
  • [47] Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type I (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp160 of HIV-1 and boosted with a recombinant gp160
    Fleury, B
    Janvier, G
    Pialoux, G
    Buseyne, F
    Robertson, MN
    Tartaglia, J
    Paoletti, E
    Kieny, MP
    Excler, JL
    Riviere, Y
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 734 - 738
  • [48] HIV-1-ENV SPECIFIC CYTOTOXICITY IN PATIENTS WITH ASYMPTOMATIC HIV DISEASE BEFORE AND AFTER IMMUNIZATION WITH RECOMBINANT GP160
    PONTESILLI, O
    VARANI, AR
    CARLESINO, M
    FANALESBELASIO, E
    BERNARDI, L
    ALARIO, C
    GUERRA, EC
    RICCI, G
    AIUTI, F
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1994, 7 (03) : 251 - 260
  • [49] HIV-1 envelope glycoprotein (gp160) enhanced Fas and ceramide induced apoptosis is inhibited by calmodulin antagonists.
    Micoli, KJ
    McDonald, JM
    FASEB JOURNAL, 1997, 11 (03): : 3092 - 3092
  • [50] T-CELLS, V-GENES, AND HIV
    BANSAL, AS
    GREEN, LM
    PUMPHREY, RSH
    MANDAL, B
    LANCET, 1992, 339 (8809): : 1604 - 1604
12345